Fortis Healthcare Ltd
Fortis Healthcare Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 3 strong
Not discussed on this call: margin, order book.
The short version
Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform. Fortis Healthcare, supported by IHH, remains fully committed to growth with plans for capital infusion as needed.
From Fortis Healthcare Ltd's Q1 FY27 earnings-call transcript · updated 18 Sept 2026.
Revenue & Sales Performance
- Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform.
- IHH Healthcare has the ability and willingness to invest additional capital as needed for Fortis' expansion, including brownfield projects and M&A opportunities.
- Operationally, Fortis has built a resilient and fully operational leadership team insulated from ongoing legal proceedings, ensuring steady execution.
- Competitive intensity in the healthcare sector is increasing; Fortis plans to step up efforts to maintain and grow its market position.
- Growth initiatives such as bed expansion, capital expenditure, and acquisitions will continue without constraint.
- No legal ordeals or forensic audits are expected to impede business growth or capital infusion plans in the near term.
Profitability & Margins
See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- IHH remains fully committed to Fortis Healthcare and its growth plans.
- There is no change in commitment to invest capital as needed for Fortis' expansion.
- IHH can infuse more capital within legal limits over the next 6 to 12 months and beyond.
- Growth plans including brownfield expansion and M&A activities will continue actively.
- IHH has no impediments to investing in Fortis and supporting its growth engine in India.
- The recent legal and forensic audit developments do not restrict corporate actions or capital infusion by IHH.
- IHH plans to increase its stake in Fortis to over 50% in the next 3-5 years.
- Operational plans, acquisitions, and potential integration with Gleneagles remain on track.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Fortis Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.4K Cr, net profit ₹271 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fortis Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
- Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
- Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
- Health X Platform Ltd (Q1 FY27)
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Frequently Asked Questions
What were Fortis Healthcare Ltd Q1 FY27 results?
Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform. Fortis Healthcare, supported by IHH, remains fully committed to growth with plans for capital infusion as needed.
What is Fortis Healthcare Ltd share price analysis?
Fortis Healthcare Ltd currently shows a below-average growth signal. The stock trades at a P/E of 62.8 with a market cap of ₹67,025 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fortis Healthcare Ltd planning capital expenditure?
IHH remains fully committed to Fortis Healthcare and its growth plans.
Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.